Comments Off on Seven Biopharma Trends to Watch in 2022
Comments Off on Foresite’s immunology play gets a $200M megaround for TYK2 program, rebranding as Alumis
Comments Off on Top Life Sciences Startups to Watch in 2022
Comments Off on This Entrepreneur Raised $93 Million To Cure Common Diseases
Comments Off on Vikram Bajaj, PhD: “Innovation Doesn’t Come from Boston and San Francisco Alone”
